blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4084801

EP4084801 - A NOVEL VISCOELASTIC FORMULATION FOR OSTEOARTHRITIS TREATMENT AND A PRODUCTION METHOD THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  07.10.2022
Database last updated on 14.09.2024
FormerThe international publication has been made
Status updated on  10.07.2021
Most recent event   Tooltip16.03.2024Supplementary search reportpublished on 17.04.2024  [2024/16]
Applicant(s)For all designated states
VSY Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi
Istanbul Tuzla Organize
Sanayi Bölgesi 3. Cadde, No:3
Tepeoren Mevkii
Istanbul / TR
[2022/45]
Inventor(s)01 / OYTUN, Faruk
ITOSB 3 Cadde No:3 Tepeoren
Tuzla/Istanbul / TR
02 / KAYA, Busra Gizem
Istanbul Teknik Universitesi
Fen-Edebiyat Fakultesi Kimya Bl.
34469 Sariyer/Istanbul / TR
 [2022/45]
Representative(s)Dericioglu, E. Korhan
Ankara Patent Bureau
Mustafa Kemal Mahallesi Dumlupinar Bulvari
Eskisehir Yolu 9.km No:274/7 B Blok 14. Kat No:161
06530 Cankaya, Ankara / TR
[N/P]
Former [2022/45]Dericioglu, E. Korhan
Ankara Patent Bureau
Kavaklidere Mah. Bestekar Cad. No: 12/11
06680 Cankaya, Ankara / TR
Application number, filing date20910352.231.12.2020
[2022/45]
WO2020TR51471
Priority number, dateTR2019002290731.12.2019         Original published format: TR 201922907
[2022/45]
Filing languageTR
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021137837
Date:08.07.2021
Language:EN
[2021/27]
Type: A1 Application with search report 
No.:EP4084801
Date:09.11.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 08.07.2021 takes the place of the publication of the European patent application.
[2022/45]
Search report(s)International search report - published on:TR08.07.2021
(Supplementary) European search report - dispatched on:EP15.03.2024
ClassificationIPC:A61K31/728, A61K31/737, A61P19/02
[2022/45]
CPC:
C08L5/08 (EP); A61K31/728 (EP); A61K31/737 (EP);
A61P19/02 (EP); C08B37/0072 (EP); C08J3/075 (EP);
C08J2305/08 (EP) (-)
C-Set:
A61K31/728, A61K2300/00 (EP);
A61K31/737, A61K2300/00 (EP);
C08L5/08, C08L5/08, C08L5/08 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/45]
TitleGerman:NEUARTIGE VISKOELASTISCHE FORMULIERUNG ZUR BEHANDLUNG VON OSTEOARTHRITIS UND VERFAHREN ZU IHRER HERSTELLUNG[2022/45]
English:A NOVEL VISCOELASTIC FORMULATION FOR OSTEOARTHRITIS TREATMENT AND A PRODUCTION METHOD THEREOF[2022/45]
French:NOUVELLE FORMULATION VISCOÉLASTIQUE POUR LE TRAITEMENT DE L'ARTHROSE ET SON PROCÉDÉ DE PRODUCTION[2022/45]
Entry into regional phase25.07.2022National basic fee paid 
25.07.2022Search fee paid 
25.07.2022Designation fee(s) paid 
25.07.2022Examination fee paid 
Examination procedure25.07.2022Examination requested  [2022/45]
Fees paidRenewal fee
12.12.2022Renewal fee patent year 03
18.12.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2009143331  (STROUMPOULIS DIMITRIOS [US], et al);
 [Y]US2013136780  (TEZEL AHMET [US], et al);
 [Y]EP3257549  (ENDO DERMA CO LTD [KR]);
 [Y]KR20180035032  (PHARMARESEARCH PROD CO LTD [KR]);
 [XY]EP3473242  (ENDO DERMA CO LTD [KR])
International search[Y]WO9704012  (AAGERUP BENGT [SE]) [Y] 6-12 * abstract, examples 1, 3, 9, claim 12 *;
 [A]US2009143331  (STROUMPOULIS DIMITRIOS [US], et al) [A] 1-12 * abstract, claim 20 *;
 [XY]WO2013144867  (FIDIA FARMACEUTICI [IT]) [X] 1-5 * abstract, page 5 lines 25-30, page 6 lines 27-30, page 8 lines 20-29, page 9 lines 27-31, page 10 lines 1-20, 29-31, page 11 lines 1-5, page 13 lines 14-27, claims 1, 2, 12, 13 * [Y] 6-12;
 [A]EP3081232  (NEW MEDIC CO LTD [KR]) [A] 1-12* abstract, paragraphs 6-8, 15 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.